Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

S. Stölting; T. Klink; C. Bela; C. Engels; T. Wagner

doi:10.5414/CPP42652

Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

S. Stölting^*, T. Klink, C. Bela, C. Engels, T. Wagner

^*Corresponding author for this work

University Hospital Hamburg-Eppendorf

9 Citations (Scopus)

Original language	English
Journal	International Journal of Clinical Pharmacology and Therapeutics
Volume	42
Issue number	11
Pages (from-to)	652-653
Number of pages	2
ISSN	0946-1965
DOIs	https://doi.org/10.5414/CPP42652
Publication status	Published - 01.01.2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5414/CPP42652

Cite this

@article{220212fc30444b8ca89d4a1b1bbaf906,

title = "Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.",

author = "S. St{\"o}lting and T. Klink and C. Bela and C. Engels and T. Wagner",

year = "2004",

month = jan,

day = "1",

doi = "10.5414/CPP42652",

language = "English",

volume = "42",

pages = "652--653",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0946-1965",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "11",

}

Stölting, S, Klink, T, Bela, C, Engels, C & Wagner, T 2004, 'Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.', International Journal of Clinical Pharmacology and Therapeutics, vol. 42, no. 11, pp. 652-653. https://doi.org/10.5414/CPP42652

Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis. / Stölting, S.; Klink, T.; Bela, C. et al.
In: International Journal of Clinical Pharmacology and Therapeutics, Vol. 42, No. 11, 01.01.2004, p. 652-653.

Research output: Journal Articles › Journal articles › Research › peer-review

TY - JOUR

T1 - Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

AU - Stölting, S.

AU - Klink, T.

AU - Bela, C.

AU - Engels, C.

AU - Wagner, T.

PY - 2004/1/1

Y1 - 2004/1/1

UR - https://www.scopus.com/pages/publications/16644393421

U2 - 10.5414/CPP42652

DO - 10.5414/CPP42652

M3 - Journal articles

C2 - 15598036

AN - SCOPUS:16644393421

SN - 0946-1965

VL - 42

SP - 652

EP - 653

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

IS - 11

ER -

Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

UN SDGs

Access to Document

Other files and links

Cite this